Insights from multi-omics on GLP-1 receptor agonists in type 2 diabetes and obesity

Frontiers in pharmacology · 2026 · Elashi AA, Hedaya L, Maggio V et

By Maren Holt · Senior Reporter, GLP-1

Oct 12 20:00 ETSource: Frontiers in pharmacology

From the source

Insights from multi-omics on GLP-1 receptor agonists in type 2 diabetes and obesity
Frontiers in pharmacology · 2026 · Elashi AA, Hedaya L, Maggio V et al.

Read at pubmed.ncbi.nlm.nih.gov

Source URL https://pubmed.ncbi.nlm.nih.gov/42947790/